XJPX
7730
Market cap920mUSD
Oct 09, Last price
1,492.00JPY
1D
1.15%
1Q
-11.98%
Jan 2017
60.60%
IPO
296.69%
Name
Mani Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Mani, Inc. engages in the manufacture and supply of surgical and dental instruments in Japan, Asia, Europe, North America, and internationally. The company operates through three segments: Surgical Products, Eyeless Needle Products, and Dental Products. The company offers surgical instruments, such as maniplers, vessel knives, ENT knives, and stainless wire needles; and ophthalmic instruments, including ophthalmic sutures and knives, and trocar kits for vitrectomy. It also provides surgical eyeless, eyed, taper point, cutting, ophthalmic needles; and dental instruments, such as endodontic instruments, endodontic rotary instruments, root canal obturation, diamond and carbide burs, finishing and polishing instruments, sutures and surgical needles, endodontic micro-accessories, and endodontic accessories. Mani, Inc. was founded in 1956 and is headquartered in Utsunomiya, Japan.
Key people
Masahiko Saito
Executive Chairman, Chief Director of Quality Assurance · since 2025
Masaya Watanabe
Executive President, Chief Executive Officer, Representative Executive Officer, Director · since 2025
Kazuo Takahashi
Executive Vice President,Chief Financial Officer,Chief Risk Officer, Manager of Business Planning Office, Director · since 2025
Takayuki Yamamoto
Chief Financial Officer, Chief Risk Officer, Managing Executive Officer, Manager of Business Planning · since 2025
Hideshi Fukumoto
Global Chief Technology Officer, Senior Managing Executive Officer, Manager of Monozukuri · since 2025
Shuichi Kurita
Senior Managing Executive Officer, Manager of Business, Chief Director of Global Sales · since 2025
Tomomi Kosaka
Managing Executive Officer, Assistant Manager of Monozukuri, Chief Director of Production, Chairman of Subsidiaries · since 2024
Kentaro Inatomi
Administrative Officer, President of Subsidiary · since 2025
Noritomo Koike
Executive Officer, Chief Director of Product Business · since 2025
Kaoru Ogane
Administrative Officer, Chief Director of Global Operations · since 2025
Norio Ozaki
Executive Officer, Chief Director of Development · since 2025
Hajime Terada
Executive Officer, Chief Director of Human Resources and General Affairs · since 2025
Toshihide Takai
Director · since 2025
Yukio Matsui
Independent Director · since 2024
Chairman of the Board of Directors, Independent Director · since 2024
Yukiko Moriyama
Independent Director · since 2020
Hiroyuki Sasa
Independent Director · since 2025
Tatsushi Yano
Independent Director · since 2021
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑08 | 2024‑08 | 2023‑08 | 2022‑08 | 2021‑08 | 2020‑08 | 2019‑08 | 2018‑08 | 2017‑08 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||